A Study of LY2605541 Versus Insulin Glargine on Blood Sugar

NCT01654380 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Diabetes Mellitus, Type 1

Interventions

DRUG: LY2605541
OTHER: Insulin glargine

Sponsor

Eli Lilly and Company